IMNM earnings: a positive outcome, +17.4%

On August 5, 2022, Immunome Inc. reached its earnings. The result was a positive outcome, and the stock moved +17.4% in the window around the event. It had already run -6.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.